Clin Pediatr Hematol Oncol.  2011 Apr;18(1):75-79.

Tumor Lysis Syndrome in a Child with Osteosarcoma

Affiliations
  • 1Department of Pediatrics, College of Medicine, Hallym University, Seoul, Korea. pedsjs@hallym.or.kr

Abstract

Tumor lysis syndrome (TLS) is a metabolic derangement that may be seen after the initial treatment of cancer and usually occurs in patients with bulky, rapidly proliferating, or treatment-responsive tumors such as acute leukemia or Burkitt lymphoma. However, it is rare in the treatment of the solid tumor, especially osteosarcoma. An 11-year-old girl was admitted with a 3-months history of severe right leg pain. She was diagnosed as osteosarcoma and was treated with cisplatin and adriamycin. Three days after treatment, the values of potassium, phosphorus, uric acid were 6.4 mEq/L, 5.6 mg/dL and 8.9 mg/dL, respectively. At the same time, the value of calcium was 6.2 mg/dL. Although she was treated with proper conservative treatment including dialysis, she had significant complications such as renal failure, heart failure, hypoxic brain damage. We report a case of TLS in a girl with huge osteosarcoma.

Keyword

Tumor lysis syndrome; Osteosarcoma; Children

MeSH Terms

Burkitt Lymphoma
Calcium
Child
Cisplatin
Dialysis
Doxorubicin
Heart Failure
Humans
Hypoxia, Brain
Leg
Leukemia
Osteosarcoma
Phosphorus
Potassium
Renal Insufficiency
Tumor Lysis Syndrome
Uric Acid
Calcium
Cisplatin
Doxorubicin
Phosphorus
Potassium
Uric Acid
Full Text Links
  • CPHO
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr